A detailed history of Treasurer Of The State Of North Carolina transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Treasurer Of The State Of North Carolina holds 131,919 shares of VRTX stock, worth $66.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
131,919
Previous 130,739 0.9%
Holding current value
$66.3 Million
Previous $54.7 Million 13.14%
% of portfolio
0.26%
Previous 0.24%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $463,515 - $572,925
1,180 Added 0.9%
131,919 $61.8 Million
Q1 2024

May 09, 2024

SELL
$407.69 - $446.08 $353,467 - $386,751
-867 Reduced 0.66%
130,739 $54.7 Million
Q4 2023

Feb 12, 2024

SELL
$343.0 - $410.68 $245,931 - $294,457
-717 Reduced 0.54%
131,606 $53.5 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $241,798 - $259,158
-715 Reduced 0.54%
132,323 $46 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $19,494 - $21,818
-62 Reduced 0.05%
133,038 $46.8 Million
Q1 2023

May 04, 2023

BUY
$283.23 - $323.1 $434,758 - $495,958
1,535 Added 1.17%
133,100 $41.9 Million
Q4 2022

Feb 09, 2023

BUY
$285.76 - $321.48 $1.67 Million - $1.88 Million
5,844 Added 4.65%
131,565 $38 Million
Q3 2022

Nov 08, 2022

BUY
$273.83 - $305.53 $150,332 - $167,735
549 Added 0.44%
125,721 $36.4 Million
Q2 2022

Aug 02, 2022

BUY
$234.96 - $292.55 $1.78 Million - $2.22 Million
7,597 Added 6.46%
125,172 $35.3 Million
Q1 2022

May 10, 2022

BUY
$221.42 - $260.97 $595,841 - $702,270
2,691 Added 2.34%
117,575 $30.7 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $296,137 - $373,831
1,673 Added 1.48%
114,884 $25.2 Million
Q3 2021

Nov 03, 2021

BUY
$181.39 - $202.99 $56,230 - $62,926
310 Added 0.27%
113,211 $20.5 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $178,115 - $210,045
-950 Reduced 0.83%
112,901 $22.8 Million
Q1 2021

May 03, 2021

BUY
$207.02 - $241.31 $82,808 - $96,524
400 Added 0.35%
113,851 $24.5 Million
Q4 2020

Feb 02, 2021

BUY
$207.01 - $276.09 $105,575 - $140,805
510 Added 0.45%
113,451 $26.8 Million
Q3 2020

Nov 04, 2020

BUY
$255.65 - $303.1 $109,929 - $130,333
430 Added 0.38%
112,941 $30.7 Million
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $2.81 Million - $3.68 Million
-12,450 Reduced 9.96%
112,511 $32.7 Million
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $2.08 Million - $2.58 Million
10,400 Added 9.08%
124,961 $29.7 Million
Q4 2019

Feb 12, 2020

BUY
$166.71 - $223.91 $193,383 - $259,735
1,160 Added 1.02%
114,561 $25.1 Million
Q3 2019

Nov 07, 2019

SELL
$166.23 - $187.09 $7.82 Million - $8.81 Million
-47,070 Reduced 29.33%
113,401 $19.2 Million
Q2 2019

Aug 23, 2019

BUY
$164.61 - $190.37 $7,901 - $9,137
48 Added 0.03%
160,471 $29.4 Million
Q1 2019

Aug 07, 2019

BUY
$163.73 - $194.7 $410,798 - $488,502
2,509 Added 1.59%
160,423 $29.5 Million
Q4 2018

Aug 07, 2019

BUY
$151.91 - $192.21 $12,000 - $15,184
79 Added 0.05%
157,914 $26.2 Million
Q3 2018

Aug 07, 2019

BUY
$167.73 - $192.74 $8.86 Million - $10.2 Million
52,818 Added 50.29%
157,835 $30.4 Million
Q2 2018

Aug 07, 2019

BUY
$145.72 - $169.96 $9.62 Million - $11.2 Million
66,031 Added 169.37%
105,017 $17.8 Million
Q1 2018

Jul 24, 2019

BUY
$151.6 - $177.13 $5.91 Million - $6.91 Million
38,986 New
38,986 $6.35 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.